Summary
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN's POC demand, new products and international growth support its outlook, while U.S. channel shifts and distributor timing pose risks.
Should Investors Buy Inogen as Low Valuation Meets Execution Risk?
Inogen's steep sales-multiple discount, improving margins and firm international demand clash with U.S. sales and rental weakness.
Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists
INGN cuts its 2026 revenue outlook as U.S. channel pressure weighs, while international growth, new products and cost control offer support.
Inogen Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 103 | $808.1 | $712.76 | -$95.34 | -11.8% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 159 | $982.62 | $938.1 | -$44.52 | -4.53% |
 Anthony Scaramucci SkyBridge Capital II LLC | 1.1M | $7.81M | $6.3M | -$1.51M | -19.3% |
 Point72 Asset Management LP Point72 Asset Management LP | 171,342 | $1.06M | $985,216.5 | -$73,677.09 | -6.96% |
| CAL CSM Advisors LLC CSM Advisors LLC | 413,425 | $3.3M | $2.38M | -$925,233.5 | -28.02% |
Inogen Inc. (INGN) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Inogen Inc. ever had a stock split?
Inogen Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Kevin R. Smith CEO | NASDAQ (NGS) Exchange | 45780L104 CUSIP |
| US Country | 753 Employees | - Last Dividend | - Last Split | 14 Feb 2014 IPO Date |
Overview
Inogen, Inc. is a leading medical technology company that focuses on the development, manufacturing, and commercialization of portable oxygen concentrators. These devices are essential for patients who require supplemental long-term oxygen therapy, catering to those suffering from chronic respiratory conditions. The company's mission is to improve the quality of life for its users by offering innovative solutions that promote mobility and independence. Inogen has established a strong market presence both in the United States and internationally, serving patients, physicians, other clinicians, and third-party payors. Founded in 2001, Inogen has its headquarters in Goleta, California, from where it continues to expand its reach and impact in the medical technology space.
Products and Services
- Inogen One: This is Inogen's flagship portable oxygen concentrator, designed to enhance the mobility of patients while providing a reliable source of supplemental oxygen. By concentrating the air around the patient, the Inogen One device ensures that users have a continuous oxygen supply, supporting their respiratory needs without compromising their lifestyle.
- Inogen At Home: Recognizing the need for a stationary solution for home use, Inogen also offers the Inogen At Home oxygen concentrator. This device is engineered for efficiency and convenience, providing high-quality oxygen therapy with minimal noise and power usage, making it an ideal companion for patients at home.
- Simeox: Simeox is a technologically advanced airway clearance device offered by Inogen. It aims to assist patients with mucus clearance, enhancing their pulmonary function. This device is especially useful for individuals with conditions that lead to increased mucus production, facilitating easier breathing.
- Batteries and Accessories: In addition to the main oxygen concentrator units, Inogen provides a range of batteries and accessories to support and enhance the functionality of its products. This includes batteries for extended mobility, carrying cases, and other accessories designed to improve the user experience.
- Rental Services: Understanding that purchasing might not be the best option for all, Inogen offers rental services for its products. This allows patients to access the benefits of Inogen's oxygen concentrators without the upfront cost, providing flexibility and ease of use.
